MLSS · Milestone Scientific Inc.
$0.43
+0.03 (+6.86%)
At close · Jul 28
Going-concern doubt
— flagged May 13, 2026
Substantial doubt about the company's ability to continue as a going concern.
“These conditions raise substantial doubt about the Company’s ability to continue as a going concern. The Company’s recurring losses from operations, negative cash flows, and accumulated deficit raise substantial doubt about its ability to continue as a going concern. The completion of the private placement in April 2026 has improved the Company’s liquidity position; however, the Company’s ability to continue as a going concern is dependent upon its ability to generate sufficient revenue, manage operating expenses, and, if necessary, obtain additional financing”View the 10-Q filed May 13, 2026
Market Cap
$37.87M
Shares
88.08M
Income-statement, balance-sheet and cash-flow figures extracted from the company's SEC filings — 10-K annual and 10-Q quarterly reports — and standardised for comparison across periods.
Revenue
$8.97M
+4%
FY2025
Net Income
$5.72M
+21.4%
FY2025
Gross Margin
71.4%
-3.2pp
FY2025
Operating Margin
-63.48%
+14.8pp
FY2025
Diluted EPS
-$0.07
-16.7%
FY2025
Operating Cash Flow
-$2.92M
+0.1%
FY2025
Chart any reported metric, KPI or segment over time — the full statement history lives here
Search above to add metrics — fundamentals, product and segment revenue, company KPIs, valuation.
| Line Item | FY2026 (G) | TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | FY2015 | FY2014 | FY2013 | FY2012 | FY2011 | FY2010 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| $9.8M – $10.2M | $8.9M | $8.97M | $8.63M | $9.83M | $8.81M | $10.3M | $5.44M | $8.37M | $9.62M | $11.28M | — | — | — | — | — | — | — | |
| — | $19.55K | — | $60.27K | $125.53K | $54.61K | -$16.36K | -$18.08K | $1543 | $7447 | — | — | — | — | — | — | — | — | |
| — | $2.58M | $2.57M | $2.2M | $3.03M | $3.91M | $3.99M | $1.82M | $2.66M | $5.19M | $4.31M | $4.18M | $3.05M | $3.63M | $3.2M | $3.06M | $3.02M | $3.53M | |
| — | $6.32M | $6.41M | $6.43M | $6.79M | $4.9M | $6.31M | $3.62M | $5.72M | $4.43M | $6.97M | $6.31M | $6.44M | $6.7M | $6.81M | $5.59M | $5.36M | $6.22M | |
| — | — | 71.4% | 74.56% | 69.12% | 55.65% | 61.25% | 66.6% | 68.28% | 46.05% | 61.77% | — | — | — | — | — | — | — | |
| — | — | $449.47K | $858.77K | $701.38K | $1.15M | $878.21K | $307.85K | $189.92K | $245.64K | $272.75K | $1.27M | $100.86K | $88.24K | $191.35K | $181.98K | $140.05K | $270.49K | |
| — | $10.69M | $11.58M | $12.3M | $13.14M | $12.51M | $12.74M | $10.67M | $9.53M | $10.65M | $11.93M | $11.55M | $9.4M | $7.4M | $5.53M | $5.93M | $6.45M | $6.65M | |
| — | — | $69.34K | $30.23K | $49.32K | $49.66K | $51.63K | $53.01K | $53.01K | $814.68K | $510.68K | $70.7K | $69.43K | $78.46K | $77.95K | $76.32K | $83.3K | $83.4K | |
| — | $78.21K | $78.2K | $37.45K | $61.91K | $63.76K | $73.84K | $95.95K | $100.51K | $881.29K | $573.15K | — | — | — | — | — | — | — | |
| — | $10.85M | $12.1M | $13.19M | $13.9M | $13.73M | $13.69M | $11.07M | $9.72M | $12.43M | $12.2M | $12.82M | $9.5M | $7.49M | $5.73M | $6.11M | $6.59M | $6.92M | |
| — | -$4.53M | -$5.7M | -$6.76M | -$7.11M | -$8.83M | -$7.38M | -$7.45M | -$4M | -$8M | -$5.23M | -$6.51M | -$3.06M | -$790.18K | $1.09M | -$520.35K | -$1.22M | -$700.84K | |
| — | — | -63.48% | -78.3% | -72.31% | -100.24% | -71.6% | -137.08% | -47.75% | -83.14% | -46.4% | — | — | — | — | — | — | — | |
| — | -$4.45M | -$5.62M | -$6.72M | -$7.04M | -$8.76M | -$7.3M | -$7.36M | -$3.9M | -$7.12M | -$4.66M | — | — | — | — | — | — | — | |
| — | — | — | — | — | — | — | — | — | — | — | — | — | $2668 | $70.8K | $175.91K | $131.84K | $95.14K | |
| — | — | — | — | — | — | — | — | — | $7447 | $9298 | $1285 | $3838 | $2389 | $115 | $34 | $35 | $587 | |
| — | — | — | — | — | — | — | -$24.79K | -$10.41K | -$7232 | -$4930 | -$5088 | -$1509 | $2389 | $378.23K | — | — | $183.67K | |
| — | — | — | — | — | $0 | $242.59K | $97.89K | $81.32K | $329.7K | -$120.51K | -$795.83K | -$2.45M | -$910.2K | -$924.36K | -$171.02K | -$121.4K | — | |
| — | -$4.57M | -$5.72M | -$4.71M | -$6.98M | -$8.77M | -$7.12M | -$7.47M | -$7.64M | -$8M | -$5.23M | -$6.52M | -$3.06M | -$1.7M | $1.46M | — | — | — | |
| — | — | — | — | $0 | $0 | $333 | $15.5K | $18.13K | $23.99K | $19.09K | -$19.1K | $36.16K | $9509 | — | — | — | — | |
| — | $6.88M | $5.72M | $4.71M | $6.93M | -$8.71M | -$6.82M | -$7.34M | -$7.52M | -$7.43M | -$5.19M | -$5.95M | -$5.47M | -$1.7M | $1.46M | -$870.31K | -$1.48M | -$614.51K | |
| — | — | 63.76% | 54.62% | 70.51% | -98.87% | -66.17% | -134.94% | -89.85% | -77.24% | -45.97% | — | — | — | — | — | — | — | |
| — | — | — | $0 | -$51.84K | -$66.74K | -$58.12K | -$51.54K | -$55.87K | -$260.13K | -$182.76K | -$1.35M | -$72.38K | -$5472 | — | — | — | — | |
| USD/shares | — | — | -$0.07 | -$0.06 | -$0.10 | -$0.12 | -$0.10 | -$0.12 | -$0.16 | -$0.21 | -$0.16 | -$0.22 | -$0.26 | -$0.08 | $0.09 | -$0.05 | — | — |
| USD/shares | — | — | -$0.07 | -$0.06 | — | — | -$0.10 | -$0.12 | -$0.16 | -$0.21 | -$0.16 | -$0.22 | -$0.26 | -$0.08 | $0.08 | -$0.05 | — | — |
| shares | — | — | 82.06M | 79.79M | 72.78M | 70.61M | 68.83M | 63.06M | 45.74M | 35.3M | 32.7M | 26.97M | 21.43M | 20.06M | 17.13M | 16.08M | 15.17M | — |
| shares | — | — | 82.06M | 79.79M | — | — | 68.83M | 63.06M | 45.74M | 35.3M | 32.7M | 26.97M | 21.43M | 20.06M | 17.48M | 16.08M | 15.17M | — |
Italic rows are computed from reported lines — open a row's info icon for its formula. Values reflect the latest filing (restatements included); per-share figures on today's split basis. Click a value for its source filing.
TTM: trailing twelve months through the latest reported quarter — flows sum the last four quarters, balances take the latest. 3Y/5Y/10Y columns are trailing CAGR from the newest fiscal year; blank where an endpoint is missing or negative. (G): the company's own guidance — a (G) column is a guided period not yet reported; a G marker shows how the reported figure landed against the guided range. Non-GAAP-basis guidance (*) is shown as stated and never judged against GAAP actuals.
Price & Valuation
Multiples computed on the strict TTM/EV methodology — today's snapshot against peers, and each ratio recomputed as of past filing dates.
Valuation
EV/Revenue
—
Peer median 1.30×
EV/EBIT
—
P/E (TTM)
—
Peer median 18.34×
Peer medians compare against the 19 similar-size Medical Instruments & Supplies companies (of 50 listed).
Revenue Breakdown
Annual revenue as the company disaggregates it in its own XBRL filings. Years a component wasn't reported show a dash.
Share mode is each component's slice of the reported components that year — issuers rarely tag every revenue dollar, so slices need not sum to total revenue.
By Segment (USD)
| Component | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|---|
| Dental | $8,790,732 | $8,525,308 | — | — | — | — |
| Medical | $183,250 | $104,620 | — | — | — | — |
| Dental Segment | — | — | $9,761,444 | $8,753,156 | $10,152,511 | $5,421,436 |
| Medical Segment | — | — | $66,000 | $52,750 | $152,200 | $15,800 |
By Geography (USD)
| Component | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|---|
| United States | $4,969,215 | $5,254,331 | — | — | — | — |
| Rest of World | $3,694,767 | $3,375,597 | $4,195,564 | $4,886,070 | $4,635,034 | $3,239,650 |
| China | $310,000 | — | $270,000 | $629,964 | $2,098,128 | $77,400 |
| Domestic | — | — | $5,361,880 | $3,289,872 | $3,571,549 | $2,120,186 |
By Product & Service (USD)
| Component | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Handpieces | $7,137,757 | $6,974,648 | $7,156,632 | $6,450,876 | $8,026,884 |
| Instruments | $1,761,463 | $1,565,159 | $2,550,051 | $2,215,740 | $2,159,910 |
| Other | $74,762 | $90,121 | — | — | — |
| Accessories | — | — | $120,761 | $139,290 | $117,917 |
Segment Operating Income
Annual operating income by business segment, as tagged in the company's own XBRL filings. Segments need not sum to the consolidated figure — corporate costs and eliminations are typically unallocated.
By Segment (USD)
| Component | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|---|
| Dental | $1,923,265 | $1,574,242 | — | — | — | — |
| Medical | -$1,431,873 | -$2,055,950 | — | — | — | — |
| Dental Segment | — | $1,576,042 | $2,080,604 | $1,121,815 | $2,475,059 | $817,355 |
| Medical Segment | — | -$2,057,750 | -$3,708,171 | -$4,788,105 | -$4,105,854 | -$3,338,411 |
Operating Margin by Segment (%)
| Component | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|---|
| Dental | 21.9% | 18.5% | — | — | — | — |
| Medical | -781.4% | -1965.2% | — | — | — | — |
| Dental Segment | — | — | 21.3% | 12.8% | 24.4% | 15.1% |
| Medical Segment | — | — | -5618.4% | -9077% | -2697.7% | -21129.2% |